You are currently viewing a new version of our website. To view the old version click .
Proceedings
  • Abstract
  • Open Access

28 May 2024

Electrochemical Biosensor Based on Graphene–Folic Acid Nanobiocomposite for Detecting Overexpressed Folate Receptor in Breast Cancer Cells †

Department of Chemistry, College of Sciences, University of Sharjah, Sharjah P.O. Box 27272, United Arab Emirates
Presented at the 4th International Electronic Conference on Biosensors, 20–22 May 2024; Available online: https://sciforum.net/event/IECB2024.
This article belongs to the Proceedings The 4th International Electronic Conference on Biosensors

Abstract

Enhancing the analytical performance of biosensors is a key factor in fabricating well-organized sensing platforms with high sensitivity. The main challenge in developing selective and sensitive biosensors is the lack of a sensing architecture that allows the detection of small biomolecules at low concentrations in crowded biological media. The functionality and stability of biosensors improve when the surface patterns are in a well-organized arrangement, and when biomaterials are present at a good density. It is common to use antibodies or aptamers as capture molecules for the target analyte, but they have limitations in terms of density and orientation when immobilized on sensor surfaces. Alternatively, simple non-toxic molecules such as folic acid (FA) can be used as recognition elements. They have the ability to construct nanostructures and produce sensing devices with good selectivity and sensitivity. In this study, the conjugation of FA to reduced graphene oxide (rGO) was prepared and then used to functionalize a glassy carbon electrochemical (GCE) electrode for the detection of breast cancer cells (MCF-7). The cyclic voltammetry (CV) technique was employed to characterize the electrochemical proficiency of the developed electrode for detecting MCF-7 cells. The rGO-FA nanobiocomposite demonstrated itself as a promising substrate, offering good electrochemical signals after capturing cancer cells in the range between 1 × 103 and 1 × 105 cells/mL. The CV results indicated the successful binding of the folate receptor overexpressed on the surface of the cell membrane in the MCF-7 cells to the rGO-FA-modified sensor. The simple design of rGO-FA/GCE showed good, reliable, and satisfactory performance, which may significantly contribute to the development of low-cost biosensors for future cancer diagnosis.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

Data is contained within the article.

Conflicts of Interest

The authors declare no conflicts of interest.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.